Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access : Episode 1
Tackling Key Concerns in Atopic Dermatitis + Biologic Use
Casey Butrus, PharmD; Michael Cameron, MD, FAAD, and Brittany Craiglow, MD, address the critical clinical challenges in treating atopic dermatitis (AD) patients and discuss current trends in biologics use for AD.
Now Viewing
EP: 1.Tackling Key Concerns in Atopic Dermatitis + Biologic Use
EP: 2.Atopic Dermatitis: Topical Therapies and Unmet Needs in the Treatment Landscape
EP: 3.Going Beyond Topical Steroids and Calcineurin Inhibitors for AD Treatment
EP: 4.Experts Discuss Long-Term Effects and Monitoring in AD Therapy
EP: 5.Balancing Safety and Efficacy: Optimizing Topical Treatment Options for AD
EP: 6.The Patient Journey: Effectively Managing AD Itch Early On
EP: 7.Streamlining Prior Authorization for Topical AD Therapies: Expert Strategies
EP: 8.Experts Share Final Insights to Optimize Atopic Dermatitis Patient Care
- As it relates to the current treatment landscape for atopic dermatitis, what are the most pressing clinical concerns in treating patients with this disease?
- What trends are you seeing related to the use of biologics and injectables in the management of AD, and what are the cost implications of these trends?
Related Videos
Related Content
